Search research articles
Contact Us
Filters
Showing results (51-60 of 225) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
April 12, 2012
Parvovirus 4 infection and clinical outcome in high-risk populations
Ruth Simmons, Colin Sharp, C Patrick McClure, et al.
Antiviral Therapy
|
November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance
Monika Tschochner, Abha Chopra, Tanya M Maiden, et al.
Plos Biology
|
September 17, 2014
Disentangling human tolerance and resistance against HIV
Roland R Regoes, Paul J McLaren, Manuel Battegay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 2019
Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?
David C Boettiger, Luisa Salazar-Vizcaya, Gregory J Dore, et al.
Antiviral Therapy
|
February 7, 2009
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Christoph A Fux, Andri Rauch, Mathew Simcock, et al.
Journal of Global Antimicrobial Resistance
|
November 28, 2017
Intestinal colonisation with extended-spectrum cephalosporin-resistant Enterobacteriaceae in different populations in Switzerland: prevalence, risk factors and molecular features
João Pires, Esther Kuenzli, Christoph Hauser, et al.
The Journal of Infectious Diseases
|
August 8, 2008
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir
Sara Colombo, Andri Rauch, Margalida Rotger, et al.
AIDS (London, England)
|
November 16, 2010
A randomized crossover study to compare efavirenz and etravirine treatment
Alain Nguyen, Alexandra Calmy, Cécile Delhumeau, et al.
The Journal of Infectious Diseases
|
August 1, 2013
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
Gilles Wandeler, Thomas Gsponer, Florian Bihl, et al.
BMC Infectious Diseases
|
October 12, 2019
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
Bernard Surial, Matthias Cavassini, Alexandra Calmy, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 225) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
April 12, 2012
Parvovirus 4 infection and clinical outcome in high-risk populations
Ruth Simmons, Colin Sharp, C Patrick McClure, et al.
Antiviral Therapy
|
November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance
Monika Tschochner, Abha Chopra, Tanya M Maiden, et al.
Plos Biology
|
September 17, 2014
Disentangling human tolerance and resistance against HIV
Roland R Regoes, Paul J McLaren, Manuel Battegay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 2019
Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?
David C Boettiger, Luisa Salazar-Vizcaya, Gregory J Dore, et al.
Antiviral Therapy
|
February 7, 2009
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Christoph A Fux, Andri Rauch, Mathew Simcock, et al.
Journal of Global Antimicrobial Resistance
|
November 28, 2017
Intestinal colonisation with extended-spectrum cephalosporin-resistant Enterobacteriaceae in different populations in Switzerland: prevalence, risk factors and molecular features
João Pires, Esther Kuenzli, Christoph Hauser, et al.
The Journal of Infectious Diseases
|
August 8, 2008
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir
Sara Colombo, Andri Rauch, Margalida Rotger, et al.
AIDS (London, England)
|
November 16, 2010
A randomized crossover study to compare efavirenz and etravirine treatment
Alain Nguyen, Alexandra Calmy, Cécile Delhumeau, et al.
The Journal of Infectious Diseases
|
August 1, 2013
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
Gilles Wandeler, Thomas Gsponer, Florian Bihl, et al.
BMC Infectious Diseases
|
October 12, 2019
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
Bernard Surial, Matthias Cavassini, Alexandra Calmy, et al.
Page
of 23